December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Tyrosinase Activity and VER Asymmetry in Oculo-Cutaneous Albinism (OCA)
Author Affiliations & Notes
  • J Shankar
    Department of Ophthalmology Clinical Engineering
    Royal Liverpool Children's Hospital Liverpool United Kingdom
  • J Nair Sahni
    Department of Ophthalmology Clinical Engineering
    Royal Liverpool Children's Hospital Liverpool United Kingdom
  • R Hagan
    Department of Ophthalmology Clinical Engineering
    Liverpool University Liverpool United Kingdom
  • SB Kaye
    Department of Ophthalmology Clinical Engineering
    Royal Liverpool Children's Hospital Liverpool United Kingdom
  • D Isherwood
    Clinical Biochemisry Department of Ophthalmology
    Royal Liverpool Children's Hospital Liverpool United Kingdom
  • M Brown
    Department of Ophthalmology Clinical Engineering
    Liverpool University Liverpool United Kingdom
  • C Willoughby
    Clinical Biochemisry Department of Ophthalmology
    Liverpool University Liverpool United Kingdom
  • A Fryer
    Clinical Genetics University Liverpool Liverpool United Kingdom
  • Footnotes
    Commercial Relationships   J. Shankar, None; J. Nair Sahni, None; R. Hagan, None; S.B. Kaye, None; D. Isherwood, None; M. Brown, None; C. Willoughby, None; A. Fryer, None. Grant Identification: none
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1805. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J Shankar, J Nair Sahni, R Hagan, SB Kaye, D Isherwood, M Brown, C Willoughby, A Fryer; Tyrosinase Activity and VER Asymmetry in Oculo-Cutaneous Albinism (OCA) . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1805.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To assess the correlation between tyrosinase activity and Visual Evoked Response (VER) asymmetry in patients with oculo-cutaneous albinism (OCA). Methods: Patients with clinically diagnosed OCA underwent electro-diagnostic testing (EDT) including flash and pattern reversal VER recording. The inter-hemispherical difference between the right and the left eyes were calculated for 200 ms and 150 ms using Pearson's correlation coefficient. Tyrosinase activity was assessed by observing microscopically, the production of melanin granules in hair roots after incubation for 8 hours in phosphate buffer (pH 6.8) containing 400mg/L of tyrosine alone or with 400mg/L of cysteine hydrochloride. The mean Pearson's correlation values were compared with the results of tyrosinase activity. Results: Twenty-five children with OCA had electro-diagnostic testing (EDT) of whom 19 had reliable and repeatable VERs for hemispherical asymmetry. The mean Pearson's correlation coefficient was -0.176 + 0.473 at 200 ms and -0.183 + 0.499 at 150 ms. Seven of the children with OCA were available for a reliable hair bulb test result to assess tyrosinase activity. There were five children with weakly positive tyrosinase activity and two who were tyrosinase negative. The mean Pearson's correlation in the weakly tyrosinase positive group was 0.130 + 0.563 at 200 ms and 0.124 + 0.561 at 150 ms. In the two patients who were tyrosinase negative OCA, the Pearson's correlation was - 0.824 and -0.579 at 200 ms and - 0.780 and -0.638 at 150 ms respectively. Conclusion: The mean Pearsons coefficient of correlation was negative in OCA. There was a trend for patients with Tyrosine negative OCA to have a greater degree of VER asymmetry as compared to patients who had weakly positive tyrosinase activity. Overall, there was a correlation between the degree of VER asymmetry and tyrosinase activity.

Keywords: 393 electrophysiology: clinical • 621 visual cortex • 625 visual impairment: neuro-ophthalmological disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×